Vertex has the revenue power to excel during any market environment.
AI search is fundamentally changing how consumers navigate decision making, and brands must adapt in order to be discoverable ...
Legend Biotech Corporation (NASDAQ:LEGN) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Legend ...
Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in a deal that could garner up to $1.7 billion in biobucks.
EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. | EIR Biopharma is hoping to bring in $17.
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...
AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...
The company expects to expand global distributor agreements to cover over 40 countries in 2026 and to finalize VYJUVEK pricing and launch in Italy in the second half of 2026. Management reaffirmed ...
The broader Miami-Fort Lauderdale-West Palm Beach metro produced $533.7 billion in GDP in 2023, a nearly 9% year-over-year increase. 3 Migration continues to rise with a reported 123,471 new residents ...
Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.
Despite the headline jump, local brokers describe a market that still feels slow. As reported by Crain's New York Business, CBRE Vice Chairman William Hartman said demand is "still pretty anemic" even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results